JENNIFER MARCHAND: Open Payments
NPI 1952868051 · PORT BARRE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,806 in 99 payments from 21 companies in 2025. Trend: 2023 $541 · 2024 $1,800 · 2025 $1,806
Food & beverage: $1,684Education: $121
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $322 |
| GENZYME CORPORATION | 13 | $283 |
| Galderma Laboratories, L.P. | 20 | $265 |
| Lilly USA, LLC | 12 | $191 |
| ABBVIE INC. | 10 | $148 |
| Regeneron Healthcare Solutions, Inc. | 8 | $148 |
| Amgen Inc. | 3 | $58 |
| PFIZER INC. | 2 | $55 |
| Botanix SB Inc | 3 | $50 |
| Incyte Corporation | 2 | $43 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, TALTZ, SKYRIZI, RINVOQ, OTEZLA, SOFDRA.
Industry payments across LA — which companies pay providers there.
